Articles

Why tech giants such as Alphabet and Microsoft are the safer choice in the AI race.

“What drives me crazy is that she didn’t mention it.”

“He also wants me to downsize and move.”

Analysts expect borrowing costs in the U.K. to rise in the longer term if Andy Burnham takes over as leader of the Labour Party.

Actor Zac Efron has bid farewell to Hollywood in favor of building a unique off-grid retreat made almost entirely of hemp on a remote plot of land in Australia.

Actress Diane Keaton’s final home has returned to the market with a significant discount, just weeks after its previous listing was taken down.

Micron’s massive growth is “coming at nearly pure profit,” and that’s starting to have real implications for the S&P 500.

Warsh may hope the threat of rate hikes is enough. But stocks might gain ground if he does, and past rate-hike cycles can be a guide.

The key to a healthy breakfast is less about when you eat it and more about what you eat.

SpaceX is expected to secure index entry in the coming days and weeks, unlocking a new source of investor demand after there’s been “striking” breadth so far.

AbbVie is reportedly trying to buy a biotech company that is developing a promising atopic dermatitis drug for $10.9 billion in cash, according to a Financial Times report.

“If you find a need in your community, there’s likely an organization that will help you get involved.”